EUVIMEDEUVIMED entdecken
Open Access

The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells

Michael R Booth, Laurence Booth, Jane L Roberts, John M Kirkwood, Paul Dent

Oncotarget · 2026

DOI: 10.18632/oncotarget.28861 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, 2026. Verfasst von Michael R Booth und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Metformin, Phenylurea Compounds, Pyridines. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminPhenylurea CompoundsPyridinesHumansAutophagyAnimalsCell Line, TumorBeclin-1Autophagy-Related Protein 5Signal TransductionMice

Stichwörter der Autor:innen

BIDER stressaramcholmacroautophagyregorafenib

Substanzen

MetforminregorafenibPhenylurea CompoundsPyridinesBeclin-1Autophagy-Related Protein 5ATG5 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Melanoma and Skin Cancer Program, Hillman Cancer Research Pavilion Laboratory, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.

Zitieren

APA

Booth, M. R., Booth, L., Roberts, J. L., Kirkwood, J. M., & Dent, P. (2026). The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells. Oncotarget. https://doi.org/10.18632/oncotarget.28861

Vancouver

Booth MR, Booth L, Roberts JL, Kirkwood JM, Dent P. The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells. Oncotarget. 2026. doi:10.18632/oncotarget.28861

BibTeX
@article{Booth2026,
  author = {Booth, Michael R and Booth, Laurence and Roberts, Jane L and Kirkwood, John M and Dent, Paul},
  title = {The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells},
  journal = {Oncotarget},
  year = {2026},
  doi = {10.18632/oncotarget.28861}
}
Kostenlos starten →